Response evaluation of bone metastases in breast cancer: Value of magnetic resonance imaging

Cancer Investigation

Volumn 17, Issue 8, 1999, Pages 575-580

  Saip, Pinar ^a   Tenekeci, Nuri ^b   Aydiner, Adnan ^b   Dinçer, Maktav ^b   Inanç, Sevil ^b   Demir, Cumhur ^b   Oral, E N ^b   Topuz, Erkan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Universitesi Onkoloji E ^*

Author keywords

[No Author keywords available]

Indexed keywords

CA 15-3 ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 0032696743     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909032842     Document Type: Article

References (18)

1. Barry WF, Wells SA, Cox CE, et al: Clinical and radiographic correlations in breast cancer patients with osseous metastases. Skeletal Radiol 6:27-32, 1981.
2. Coleman RE, Rubens RD: The clinical course of bone metastases. Br J Cancer 55:61-66, 1987.
3. Lokich JJ. Osseous metastases: radiographic monitoring of therapeutic response. Oncology 35:274-276, 1978.
4. Hortobagyi G, Libshitz H, Seabold JE: Osseous metastases from breast cancer. Cancer 53:577-582, 1984.
5. Citrin DL, Hougen BS, Zwiebel W, et al: The use serial bone scans in assessing response of bone metastases to systemic treatment. Cancer 47:680-685, 1981.
6. Coombes RC, Dady P, Parsons C, et al: Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer 52:610-614, 1983.
7. Kerin MJ, McAnena OJ, O'Malley VP, et al: CA15-3: its relationship to clinical stage and progression to metastatic disease in breast cancer. Br J Surg 76:838-839, 1989.
8. Algra PR, Bloem JL, Verboom LJ, et al: Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographies 11:219-232, 1991.
9. Jones AL, Williams MP, Powles TJ, et al: Magnetic resonance imaging in the detection of skeletal metastases in patients with breast cancer. Br J Cancer 62:296-298, 1990.
10. Erleman R, Sciuk J, Bosse A, et al: Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175:791-796, 1990.
11. MacVicar DM, Olliff JFC, Pringle JP, et al: Ewing sarcoma: MR imaging of chemotherapy-induced changes with histologic correlation. Radiology 184:859-864, 1992.
12. Petit T, Buthiau D, Borel C, et al: Bone metastases as evaluable targets for clinical trials thanks to new imaging Proc Annu Meet Am Soc Clin Oncol 14:A55, 1995.
13. Takeshita T, Miyaji N, Okubo K, et al: Radiotherapy for metastatic spinal cord compression (MSCC): pain relief and referring to neurological improvement and value of MRI. International Congress of Radiation Oncology, June 21-25, Japan, 1993, p. 295.
14. Hayward JL, Carbone PP, Heuson JC, et al: Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13:89-94, 1977.
15. Coleman RE, Mashiter KB, Whitaker KB, et al: Bone scan flare predicts successful systemic therapy for bone metastases. J Nucl Med 29:1354-1359, 1988.
16. Gold RI, Seeger LL, Bassett LW, et al: An integrated approach to the evaluation of metastatic bone disease. Radiol Clin North Am 28:471-483, 1990.
17. Vinholes J, Coleman R, Eastell R: Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev 22:289-331, 1996.
18. Blomqvist C, Elomaa I, Ristelli J, et al: The response evaluation of bone metastasis in mammary carcinoma. The value of radiology, scintigraphy and biochemical markers of bone metabolism. Cancer 60:2907-2912, 1987.